Keywords: Shire, Manufacturing lat, Lexington, Vpriv, Gaucher disease, EMA, Replagal, Fabry disease

EMA approves Shire Vpriv plant in USA

Article | 23 February 2012

Ireland-headquartered biopharma firm Shire (LSE: SHP) says that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Shire

Go to company listing

Related Drugs

Vpriv

Replagal

Go to drug listing